Indicaid
Indicaid COVID-19 (POC)Antigen Rapid Test
Indicaid COVID-19 (POC)Antigen Rapid Test
At Home Covid-19 Test
$145 SALE (BOX OF 25)
Couldn't load pickup availability
The INDICAID™ COVID-19 Rapid Antigen Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2. Direct anterior nasal swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within the first five (5) days of symptom onset. Anterior nasal swab specimens may be collected by a healthcare provider (HCP) or self-collected (by individuals 18 years of age or older, under the supervision of an HCP).
Product Highlights
Product Highlights
- For use with direct anterior nasal and nasopharyngeal swab specimens, non-invasive test procedures
- Rapid results within 20 minutes
- Detect SARS-CoV-2 nucleocapsid protein antigen
- Effective in Detecting Omicron Variant (B.1.1.529) and specific variants of new coronavirus.*
- Accuracy: Sensitivity 81.7%; Specificity 99.4%; Overall accuracy 93.4%
CLIA license Required to purchase this product
Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate complexity, high complexity, or waived tests. This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
